## Background: The combination of uracil and tegafur in a 4:1 molar concentration (uft) has a greater antitumor activity than 5-fluorouracil (5-fu) and tegafur. because the combination of 5-fu and cisplatin has been proven to have a synergistic antitumor effect in many experimental and clinical stu
Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma
β Scribed by Yoon T. Jeen; So Y. Yoon; Sang W. Shin; Byung S. Kim; Young J. Mok; Chong S. Kim; Jin H. Hyun; Jun S. Kim; Yeul H. Kim
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 79 KB
- Volume
- 91
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. Gastric carcinoma is a substantial health problem in Turkey, and the majority of patients present with inoperable disease. The aim of this randomized trial was to assess the activity of 5-fluorouracil versus etoposide when combined with epirubicin plus cisplatin in patients with adv
## BACKGROUND. Protracted oral administration of tegafur (TG) and leucovorin (LV) attempts to simulate the continuous infusion of 5-fluorouracil, with a higher intracellular folate pool. In a prior dose-finding study with a fixed TG dose of 0.75 g/m 2 /day for a period of 21 days and continuous or
Conducted as a collaborative trial of North Central Cancer Treatment Group and Mayo Clinic.